Glycopeptide and daptomycin susceptibility and vancomycin heteroresistance of methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates from a Greek university hospital

International Journal of Antimicrobial Agents

Volumn 38, Issue 5, 2011, Pages 451-452

  Panagea, Theofano ^a   Galani, Irene ^a   Souli, Maria ^a   Karantani, Irene ^a   Giamarellou, Helen ^b   Petrikkos, George ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b HYGEIA HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; RIFAMPICIN; TEICOPLANIN; TELAVANCIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; GREECE; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GLYCOPEPTIDES; GREECE; HOSPITALS, UNIVERSITY; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE;

EID: 80053361110     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.06.011     Document Type: Letter

References (5)

1. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21. Wayne, PA: CLSI; 2011.
2. T.R. Walsh, A. Bolmström, A. Qwärnström, P. Ho, M. Wootton, and R.A. Howe Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides J Clin Microbiol 39 2001 2439 2444 (Pubitemid 32606216)
3. F.C. Tenover The quest to identify heterogeneously resistant vancomycin-intermediate Staphylococcus aureus strains Int J Antimicrob Agents 36 2010 303 306
4. P.A. Moise, G. Sakoulas, A. Forrest, and J.J. Schentag Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia Antimicrob Agents Chemother 51 2007 2582 2586 (Pubitemid 47047340)
5. P.G. Kelley, W. Gao, P.B. Ward, and B.P. Howden Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure J Antimicrob Chemother 66 2011 1057 1060